|
Join us at Good Pharmacovigilance Practice symposium to hear MHRA inspectors deliver insightful presentations and discussions on the key topics and compliance trends in pharmacovigilance, including:
Adapting to the COVID-19 pandemic: perspectives from MHRA and FDA
Hear first-hand from our speakers about the differences between the MHRA and FDA additional risk management measures inspection programmes; the type of measures included within these programmes, how inspectors collaborate with assessors regarding these programmes; what you can expect from an MHRA and FDA inspection in this area and what the common inspection from both Agencies are.
Overview of the ARMM/REMs inspection programmes In the UK and US
As the world adjusted to the COVID-19 pandemic, regulatory oversight had to adapt too. Theses presentations will review how the MHRA and US FDA pharmacovigilance inspection programmes evolved during the pandemic and will discuss how these changes will influence the future of the programmes.
Date: Thursday 10 and Friday 11 March 2022
Registration fees: £350 + VAT
Combination tickets available with the Good Clinical Practice (GCP) Symposium
CPD credits: 7.25 credits available for full attendance (10-11 March)
Should you have any queries, please contact the Events Team:
Email: mhrasymposia@glasgows.co.uk
Telephone: +44 1772 767704
We look forward to having you join us.
The Medicines and Healthcare products Regulatory Agency
|
